Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Dec;14(6):779–784. doi: 10.1111/j.1365-2125.1982.tb02036.x

Pharmacokinetic studies of various preparations of glyceryl trinitrate.

A Bashir, M J Lewis, A H Henderson
PMCID: PMC1427551  PMID: 6817769

Abstract

1 The pharmacokinetics and pharmacodynamics of five pharmaceutical preparations of glyceryl trinitrate (GTN) have been studied in six healthy volunteers. 2 Peak plasma GTN levels of 1.4 +/- 0.1 ng/ml were achieved at 3 min after sublingual administration (0.5 mg); 2.8 +/- 0.6 ng/ml and 2.5 +/- 0.3 ng/ml at 2 h and 4 h after Nitrocontin (6.4 mg) and Sustac (6.4 mg) respectively; 2.7 +/- 0.1 ng/ml and 2.5 +/- 0.2 ng/ml at 30 min after the cream (23 mg) and ointment (35 mg) respectively. 3 The mean times to reach half peak plasma GTN levels were 4.2 +/- 0.7 min after sublingual GTN, 6.5 +/- 0.9 h after Nitrocontin, 4.1 +/- 0.7 h after Sustac, 46.1 +/- 10.2 min after the ointment and 50.2 +/- 39.2 min after the cream. 4 Plasma nitrate (NO3) levels were undetectable after sublingual administration; peak NO3 levels were 0.48 +/- 0.03 microgram/ml at 4 h after Nitrocontin, 0.45 +/- 0.02 microgram/ml at 6 h after Sustac, 0.68 +/- 0.04 microgram/ml at 6 h (end of study) after the ointment and 0.63 microgram/ml at 4 h after the cream. 5 Plasma nitrite (NO2) was undetectable after sublingual GTN and peak NO2 levels were 0.48 +/- 0.04 microgram/ml at 2 h after Nitrocontin, 0.48 +/- 0.02 microgram/ml at 2 h after Sustac, 0.69 +/- 0.02 microgram/ml at 1 h after the ointment and 0.64 +/- 0.02 microgram/ml at 1 h after the cream. 6 Blood pressure (BP) declined throughout the 11 min of the study after sublingual GTN but did not change significantly after Nitrocontin or Sustac. After the ointment and the cream BP fell to the lowest level 30-60 min after administration and remained low throughout the 6 h of the study. 7 Heart rate (HR) increased to a maximum 5 min after sublingual administration with no significant increase after Nitrocontin or Sustac. After the ointment and the cream HR increased gradually to a maximum 30-60 min after administration remaining high throughout the rest of the study.

Full text

PDF
779

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong P. W., Armstrong J. A., Marks G. S. Blood levels after sublingual nitroglycerin. Circulation. 1979 Mar;59(3):585–588. doi: 10.1161/01.cir.59.3.585. [DOI] [PubMed] [Google Scholar]
  2. Axelrod H. D., Engel N. A. Fluorometric determination of sub-nanogram levels of nitrite using 5-aminofluorescein. Anal Chem. 1975 May;47(6):922–924. doi: 10.1021/ac60356a054. [DOI] [PubMed] [Google Scholar]
  3. Blumenthal H. P., Fung H. L., McNiff E. F., Yap S. K. Plasma nitroglycerin levels after sublingual, oral and topical administration. Br J Clin Pharmacol. 1977 Apr;4(2):241–242. doi: 10.1111/j.1365-2125.1977.tb00703.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bogaert M. G., Rosseel M. T., De Schaepdryver A. F. The metabolic fate of nitroglycerin (trinitrin) in relation to its vascular effects. Eur J Pharmacol. 1970 Oct;12(2):224–230. doi: 10.1016/0014-2999(70)90068-3. [DOI] [PubMed] [Google Scholar]
  5. Lorenzetti O. J., Tye A., Nelson J. W. Blood nitrite and nitrate concentration after oral and intravenous administration of glyceryl trinitrate in rabbits. J Pharm Sci. 1966 Jan;55(1):105–106. doi: 10.1002/jps.2600550124. [DOI] [PubMed] [Google Scholar]
  6. Needleman P., Blehm D. J., Rotskoff K. S. Relationship between glutathione-dependent dentration and the vasodilator effectiveness of organic nitrates. J Pharmacol Exp Ther. 1969 Feb;165(2):286–288. [PubMed] [Google Scholar]
  7. Needleman P., Hunter F. E., Jr The transformation of glyceryl trinitrate and other nitrates by glutathione-organic nitrate reductase. Mol Pharmacol. 1965 Jul;1(1):77–86. [PubMed] [Google Scholar]
  8. Ross P. J., Lewis M. J., Sheridan D. J., Henderson A. H. Adrenergic hypersensitivity after beta-blocker withdrawal. Br Heart J. 1981 Jun;45(6):637–642. doi: 10.1136/hrt.45.6.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rosseel M. T., Bogaert M. G. GLC determination of nitroglycerin and isosorbide dinitrate in human plasma. J Pharm Sci. 1973 May;62(5):754–758. doi: 10.1002/jps.2600620510. [DOI] [PubMed] [Google Scholar]
  10. Thadani U., Manyari D., Parker J. O., Fung H. L. Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate. Circulation. 1980 Mar;61(3):526–535. doi: 10.1161/01.cir.61.3.526. [DOI] [PubMed] [Google Scholar]
  11. Wei J. Y., Reid P. R. Quantitative determination of trinitroglycerin in human plasma. Circulation. 1979 Mar;59(3):588–592. doi: 10.1161/01.cir.59.3.588. [DOI] [PubMed] [Google Scholar]
  12. Yap P. S., McNiff E. F., Fung H. L. Improved GLC determination of plasma nitroglycerin concentrations. J Pharm Sci. 1978 Apr;67(4):582–584. doi: 10.1002/jps.2600670445. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES